Jones Financial Companies Lllp Purchases 3,162 Shares of Synopsys, Inc. $SNPS

Jones Financial Companies Lllp grew its position in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) by 69.4% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 7,716 shares of the semiconductor company’s stock after buying an additional 3,162 shares during the quarter. Jones Financial Companies Lllp’s holdings in Synopsys were worth $3,766,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Alpine Bank Wealth Management raised its stake in shares of Synopsys by 89.3% during the 3rd quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock worth $26,000 after purchasing an additional 25 shares during the period. TFC Financial Management Inc. raised its position in Synopsys by 1,250.0% in the third quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company’s stock worth $27,000 after acquiring an additional 50 shares during the period. Millstone Evans Group LLC bought a new stake in Synopsys in the third quarter worth about $27,000. SOA Wealth Advisors LLC. purchased a new position in Synopsys in the third quarter valued at about $28,000. Finally, McIlrath & Eck LLC bought a new position in shares of Synopsys during the 3rd quarter valued at approximately $29,000. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Insider Buying and Selling

In other news, insider Janet Lee sold 250 shares of the stock in a transaction on Monday, January 12th. The shares were sold at an average price of $530.00, for a total value of $132,500.00. Following the transaction, the insider owned 11,959 shares of the company’s stock, valued at $6,338,270. This represents a 2.05% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Shelagh Glaser sold 3,657 shares of Synopsys stock in a transaction on Friday, December 19th. The stock was sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the sale, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at $8,221,058.34. This represents a 17.01% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 4,157 shares of company stock valued at $1,945,036. Corporate insiders own 0.62% of the company’s stock.

Synopsys Stock Up 4.0%

Shares of NASDAQ:SNPS opened at $426.88 on Friday. The firm has a fifty day moving average price of $479.33 and a two-hundred day moving average price of $495.89. The company has a market cap of $81.67 billion, a price-to-earnings ratio of 53.43, a PEG ratio of 3.55 and a beta of 1.12. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.62 and a quick ratio of 1.52. Synopsys, Inc. has a one year low of $365.74 and a one year high of $651.73.

Synopsys (NASDAQ:SNPSGet Free Report) last posted its quarterly earnings data on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.79 by $0.11. The company had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a return on equity of 7.89% and a net margin of 18.89%.The firm’s quarterly revenue was up 37.8% on a year-over-year basis. During the same quarter last year, the company earned $3.40 earnings per share. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. Analysts anticipate that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

Wall Street Analyst Weigh In

SNPS has been the subject of several research reports. Morgan Stanley increased their price objective on Synopsys from $510.00 to $550.00 and gave the company an “overweight” rating in a report on Friday, December 12th. Rosenblatt Securities upgraded Synopsys from a “neutral” rating to a “buy” rating and cut their price target for the stock from $605.00 to $560.00 in a research note on Tuesday, December 9th. Wall Street Zen upgraded Synopsys from a “sell” rating to a “hold” rating in a research note on Saturday, December 13th. Zacks Research raised shares of Synopsys from a “strong sell” rating to a “hold” rating in a report on Monday, November 10th. Finally, KeyCorp lifted their target price on shares of Synopsys from $575.00 to $600.00 and gave the stock an “overweight” rating in a research note on Thursday, December 11th. Nine investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $553.57.

Get Our Latest Analysis on Synopsys

Synopsys Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Read More

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.